The Chamomile Powder Extract 10:1 from CONIUNCTA® (INCI: Chamomilla Recutita) is a spray-dried flower extract powder that transfers the characteristic phytochemistry of the chamomile flower into a dry, dosable form. As a 10:1 concentrate with maltodextrin as carrier, this raw material is aimed at formulators in the cosmetics and food industries seeking an anhydrous, easy-to-handle chamomile base for powder applications, capsules, sticks, or reconstitutable systems. This article examines origin, marker compound, carrier system, and documented application profile based on TDS and CDS.
Powder Form Instead of a Carrier Liquid: What Sets the 10:1 Concentrate Apart
Unlike liquid chamomile extracts based on glycerin or oil, this raw material is available as a brown powder. According to the TDS, ethanol and water serve as extraction solvents; after extraction, the concentrate is spray-dried with maltodextrin as carrier. The documented composition is 80 to 99% chamomile extract and 1 to 20% maltodextrin. The extract ratio of 10:1 describes the concentration relative to the starting flower material.
The particle fineness is specified in the TDS as 80 mesh (at least 95% passing through 80 mesh), with a bulk density of 0.50 to 0.70 according to product data. These parameters are relevant for formulators when it comes to dry blends, flow behavior, and weighing. The color ranges from golden yellow to light brown; a note in the dossier indicates that color changes may occur depending on storage and temperature, which is typical for a natural plant extract powder.
Apigenin-7-glucoside as the Primary Marker
The primary marker of chamomile listed in the CDS is apigenin-7-glucoside, a flavone glycoside. The content in the dried plant material is stated as 0.3 to 1%, with an indicative content in the product of 21 to 90 mg/g. The Ph. Eur. (minimum requirement of 0.25% apigenin-7-glucoside) and ESCOP serve as references. This marker is suitable as an analytical reference point for batch evaluation.
Beyond the flavone, the CDS documents further characteristic compounds of the chamomile flower: (-)-alpha-bisabolol, which occurs at 0.1 to 0.5% of the flower in the essential oil, as well as chamazulene, which is formed from matricin and is likewise attributable to the essential oil. These figures describe the phytochemical profile of the raw material. Batch-specific analytical data are available upon request and by prior arrangement, according to the CDS.
Documented Application Profile in Cosmetics
For cosmetic application, the CDS lists the properties soothing and anti-inflammatory, each based on the phytochemical profile and published literature. The dossier explicitly notes that these claims require independent substantiation in accordance with Regulation (EC) No. 655/2013. Formulators should therefore substantiate efficacy claims in the finished product accordingly.
In the
